Erectile dysfunction affects over half of men aged 40–70, yet most treatments only mask symptoms temporarily. PRP injection works by concentrating growth factors from your own blood and injecting them into penile tissue, stimulating new blood vessel formation and tissue repair. Unlike oral medications that fade within hours, PRP triggers lasting structural changes in penile tissue—addressing the root vascular and endothelial dysfunction that drives ED.
Erectile function depends on precise vascular mechanics: blood must flow into the corpus cavernosum (the spongy tissue that fills with blood during arousal) while venous outflow is restricted. When endothelial cells lining penile arteries become dysfunctional, blood flow diminishes and erections weaken. Reduced penile blood flow, arterial insufficiency or stenosis, venous leakage, and endothelial dysfunction are the main causes of vasculogenic erectile dysfunction.
PRP addresses this at the cellular level. The treatment concentrates platelets—which contain dozens of bioactive growth factors—and delivers them directly into damaged penile tissue. These growth factors trigger a cascade of biological events that restore vascular function.
| Growth Factor | Primary Function in ED Recovery |
| VEGF (Vascular Endothelial Growth Factor) | Stimulates new blood vessel formation (neovascularization) |
| PDGF (Platelet-Derived Growth Factor) | Recruits stem cells and promotes tissue repair |
| FGF (Fibroblast Growth Factor) | Enhances endothelial cell function and elasticity |
| IGF-1 (Insulin-Like Growth Factor) | Supports nerve regeneration and tissue remodelling |
The result: new capillaries form within penile tissue, endothelial function improves, and blood flow capacity increases. PRP is most promising for men with mild to moderate erectile dysfunction related to vascular changes—the most common underlying cause.
PRP extraction follows a precise biological protocol. A small blood sample is drawn and placed in a centrifuge, which separates blood components by density. Platelets and plasma concentrate at the top layer—typically 5–10 times more concentrated than baseline blood. This concentrated plasma contains the growth factors that trigger tissue repair.
The mechanism differs fundamentally from oral ED medications. Sildenafil and tadalafil work through temporary chemical signalling—they relax smooth muscle and increase blood flow for 4–36 hours, then wear off. PRP initiates biological regeneration that persists long after the injection. This regenerative approach is closely related to how PRP therapy works for pain management—concentrated growth factors drive genuine structural repair rather than symptom masking, regardless of the target tissue.
While conventional treatments focus on symptom management, regenerative therapies like platelet-rich plasma aim to address underlying causes, offering curative potential. This distinction matters clinically. A man taking sildenafil must plan sexual activity around medication timing and tolerates side effects like headaches and flushing. A man treated with PRP experiences progressive improvement as tissue regenerates, with no ongoing medication burden.
Clinical evidence supports this approach. 69% of men receiving the PRP shot achieved clinically meaningful improvement at six months, compared to only 27% in the placebo group. These improvements reflect genuine structural change, not temporary chemical effect.
Side effects were rare and mild—primarily minor bruising at injection sites resolving within days. This safety profile contrasts sharply with oral medications, which carry cardiovascular risks for some patients and cause persistent side effects in 10–30% of users.
The P-Shot (Priapus Shot) is the branded protocol for penile PRP injection. The procedure is minimally invasive, office-based, and requires no anaesthesia or downtime. Understanding the exact steps helps patients prepare mentally and manage expectations.
The entire treatment takes 30–45 minutes from arrival to discharge. Topical anaesthetic is applied, followed by a local nerve block for comfort. A blood sample is drawn and processed to prepare PRP. The PRP is then injected into specific areas of the penis.
Precision matters. The injections target the corpus cavernosum (the erectile tissue) and surrounding vascular zones where growth factors will have maximum impact. Multiple injection points—typically 3–5 sites—ensure even tissue distribution and optimal regeneration. Before committing to a treatment course, a Private GP in London on Harley Street can provide a comprehensive cardiovascular and hormonal health assessment, ensuring there are no underlying contraindications and that the treatment protocol is matched precisely to your individual physiology.
The use of autologous (patient’s own) biological material eliminates rejection risk and regulatory complications. Unlike synthetic fillers or stem cell products, PRP requires no special licensing—it’s classified as a biological concentrate of the patient’s own tissue.
One major advantage of PRP over surgical ED treatments is the absence of downtime. Patients return to work the same day. Sexual activity can resume within 3–5 days, though many clinicians recommend waiting one week to allow initial swelling to resolve.
| Timeline | What to Expect |
| Immediately post-treatment | Mild discomfort at injection sites; no pain |
| 24–48 hours | Possible mild swelling or bruising (normal, resolves quickly) |
| 3–5 days | Sexual activity can resume; initial sensitivity improvements may appear |
| 2–4 weeks | Increased erectile rigidity and sensitivity; improved arousal response |
| 8–12 weeks | Full results as new blood vessels mature; sustained improvements in function |
| 12–18 months | Results plateau; optional maintenance treatment can extend benefits |
Results are progressive, not immediate. This differs from oral medications, which work within 30–60 minutes. Patients must understand that tissue regeneration takes time—but the payoff is durability. Results lasted up to 6 months, with many patients reporting stronger, more sustainable erections. Many men report benefits extending 12–18 months or longer. Optimising your nutrition throughout the treatment period—ensuring sufficient intake of nitrate-rich foods, antioxidants, and vascular-supportive micronutrients—can meaningfully extend the durability of the regenerative results.
The ED treatment landscape includes oral medications, injectables, devices, and surgical options. PRP occupies a unique position: it’s non-surgical, regenerative, and addresses underlying pathology rather than masking symptoms. Understanding how PRP compares to alternatives helps patients make informed decisions.
Oral ED medications (phosphodiesterase-5 inhibitors like sildenafil and tadalafil) remain the first-line treatment globally. They work quickly and are affordable. However, they address symptoms, not causes. Most recommended treatments increase penile hemodynamics to improve erectile function without altering the pathophysiologic causes of ED.
Some patients use both approaches: PRP for tissue regeneration, medications for acute sexual situations. This combination approach is safe and increasingly common in clinical practice.
The injectable ED market includes synthetic fillers, stem cell products, and other biologics. PRP stands apart because it uses the patient’s own growth factors—no foreign substances, no regulatory delays, no rejection risk.
PRP is an effective alternative modality of treatment in cases of ED, and they offer an intermediate stage between pharmaceutical therapy and surgical interventions at least in mild and mild to moderate cases. This positioning reflects clinical reality: PRP bridges the gap between medications (which don’t address pathology) and surgery (which is irreversible). Female partners experiencing their own intimacy concerns—whether related to the psychological impact of their partner’s ED or independent issues—can explore non-surgical sexual rejuvenation for women, which applies the same evidence-based regenerative principles to female intimate health.
Important disclaimer: Always consult a qualified doctor before choosing any ED treatment. Individual results vary based on ED severity, underlying causes, age, and overall health.
What is the best injection for erectile dysfunction in the UK? PRP injection is considered the best regenerative injectable option because it uses your own growth factors to address underlying vascular dysfunction, with clinical evidence showing 69% of men achieving meaningful improvement.
How much do PRP injections cost in the UK? PRP injection costs typically range from £1,500–3,000 per treatment at private UK clinics, with results lasting 12–18 months, making the cost-per-month lower than ongoing oral medications.
Can PRP cure erectile dysfunction permanently? PRP can produce sustained improvements lasting 12–18 months by regenerating penile tissue, though results are not permanent; maintenance treatments every 12–18 months can extend benefits indefinitely.
How long do results from PRP injection for ED last? Initial improvements appear within 2–4 weeks; full results develop over 8–12 weeks and typically last 12–18 months before optional maintenance treatment.
Is PRP penile rejuvenation available on the NHS? PRP for ED is not routinely available on the NHS; it is offered exclusively through private aesthetic and sexual health clinics in the UK.
What are the risks and side effects of the P-Shot? Side effects are minimal and mild—primarily temporary bruising or swelling at injection sites resolving within days; serious complications are extremely rare when performed by qualified practitioners.
Dr SW Clinics
We offer 0% finance on all our treatments, please call the clinic to find out more +44 (0)20 3006 8459